SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001144204-18-053807
Filing Date
2018-10-15
Accepted
2018-10-15 14:59:09
Documents
13
Period of Report
2018-10-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tv504760_8k.htm 8-K 35861
2 EXHIBIT 1.1 tv504760_ex1-1.htm EX-1.1 291015
3 EXHIBIT 3.1 tv504760_ex3-1.htm EX-3.1 121249
4 EXHIBIT 3.2 tv504760_ex3-2.htm EX-3.2 21057
5 EXHIBIT 4.1 tv504760_ex4-1.htm EX-4.1 211556
6 EXHIBIT 99.1 tv504760_ex99-1.htm EX-99.1 14464
7 EXHIBIT 99.2 tv504760_ex99-2.htm EX-99.2 13907
8 GRAPHIC tv504760_ex3-1img2.jpg GRAPHIC 7139
9 GRAPHIC tv504760_ex3-1img1.jpg GRAPHIC 7499
10 GRAPHIC tv504760_ex3-2img1.jpg GRAPHIC 7499
11 GRAPHIC tv504760_ex3-2img2.jpg GRAPHIC 6211
12 GRAPHIC tv504760_ex99-1img1.jpg GRAPHIC 21253
13 GRAPHIC tv504760_ex99-2img2.jpg GRAPHIC 5598
  Complete submission text file 0001144204-18-053807.txt   787642
Mailing Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850
Business Address 9605 MEDICAL CENTER DRIVE SUITE 270 ROCKVILLE MD 20850 (734) 332-7800
Synthetic Biologics, Inc. (Filer) CIK: 0000894158 (see all company filings)

IRS No.: 133808303 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12584 | Film No.: 181122066
SIC: 2834 Pharmaceutical Preparations